Semaglutide
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes

Type of Study:
Cardiovascular

Study Length:
3.5 – 5 years

Target Age/Sex:
over 50 years of age, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov

Staus: Enrolling

Description:

Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes.

Enroll Now

Enroll Now

Address
Address
City
State/Province
Zip/Postal
If you don't have a primary care physician, just type "Do not have a primary care physician"